We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNB
426
DELISTED
Dun & Bradstreet
DNB
| $24M | 0.05% |
1,369,574
+60,978
| +5% | +$1.13M |
|
|
LCA
427
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
| $24M | 0.05% |
2,443,554
| – | – |
|
428
Flex
FLEX
$43.4B
| $23.9M | 0.05% |
1,712,683
+1,090,552
| +175% | +$13.9M |
|
429
Uranium Energy
UEC
$4.71B
| $23.8M | 0.05% |
5,177,518
+2,906,422
| +128% | +$10.7M |
|
430
Bloom Energy
BE
$52.6B
| $23.7M | 0.05% |
983,449
-138,688
| -12% | -$2.71M |
|
|
MIT
431
DELISTED
Mason Industrial Technology, Inc.
MIT
| $23.7M | 0.04% |
2,423,479
| – | – |
|
|
FSNB
432
DELISTED
Fusion Acquisition Corp. II
FSNB
| $23.7M | 0.04% |
2,416,639
| – | – |
|
433
Gogo Inc
GOGO
$515M
| $23.6M | 0.04% |
1,236,004
+797,071
| +182% | +$11.7M |
|
434
T. Rowe Price
TROW
$25B
| $23.4M | 0.04% |
154,794
-15,126
| -9% | -$2.34M |
|
435
Fortive
FTV
$19B
| $23.4M | 0.04% |
+509,503
| New | +$25.2M |
|
|
HAAC
436
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $23.4M | 0.04% |
2,374,119
| – | – |
|
437
Warrior Met Coal
HCC
$4.23B
| $23.3M | 0.04% |
628,207
-58,582
| -9% | -$1.87M |
|
438
Delta Air Lines
DAL
$55.9B
| $23.1M | 0.04% |
583,894
+583,866
| +2,085,236% | +$22.7M |
|
439
Atlassian
TEAM
$22B
| $23M | 0.04% |
78,279
+60,279
| +335% | +$18M |
|
440
Zillow
Z
$7.04B
| $23M | 0.04% |
+466,610
| New | +$25.1M |
|
|
BOAC
441
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $22.9M | 0.04% |
2,326,812
| – | – |
|
|
AL
442
DELISTED
Air Lease Corp
AL
| $22.9M | 0.04% |
+512,019
| New | +$21.4M |
|
|
SLGC
443
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $22.8M | 0.04% |
2,848,552
+391,944
| +16% | +$3.46M |
|
444
CALL
iShares China Large-Cap ETF
FXI
$4.31B
| $22.7M | 0.04% |
710,900
+667,200
| +1,527% | +$23.5M |
|
445
TripAdvisor
TRIP
$1.59B
| $22.6M | 0.04% |
834,640
+374,323
| +81% | +$9.98M |
|
|
HHLA
446
DELISTED
HH&L Acquisition Co.
HHLA
| $22.6M | 0.04% |
2,311,227
| – | – |
|
|
GSEV
447
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
| $22.6M | 0.04% |
2,307,745
+873,804
| +61% | +$8.53M |
|
448
CME Group
CME
$92.2B
| $22.5M | 0.04% |
94,564
+77,704
| +461% | +$18.2M |
|
449
Columbia Sportswear
COLM
$3.19B
| $22.4M | 0.04% |
247,944
+11,225
| +5% | +$1.04M |
|
|
EOCW
450
DELISTED
Elliott Opportunity II Corp.
EOCW
| $22.4M | 0.04% |
2,293,443
| – | – |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.